Ciclesonide nasal and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Ciclesonide nasal and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ciclesonide nasal
Brand name: Omnaris, Zetonna
Synonyms: Ciclesonide (Nasal)
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ciclesonide nasal-Insulin degludec
- Ciclesonide nasal-Insulin Degludec (U-100) Prefilled Pens
- Ciclesonide nasal-Insulin Degludec (U-100) Vials
- Ciclesonide nasal-Insulin Degludec (U-200) Prefilled Pens
- Ciclesonide nasal-Insulin degludec and liraglutide
- Ciclesonide nasal-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Ciclesonide Nasal Aerosol
- Insulin aspart, recombinant Subcutaneous-Ciclesonide Nasal Spray
- Insulin aspart, recombinant Subcutaneous-Cidaflex
- Insulin aspart, recombinant Subcutaneous-CidalEaze Cream
- Insulin aspart, recombinant Subcutaneous-Cidofovir
- Insulin aspart, recombinant Subcutaneous-Cidofovir Injection